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Efficacy of early controlled motion of the
ankle compared with no motion after non-
operative treatment of an acute Achilles
tendon rupture: study protocol for a
randomized controlled trial
Kristoffer Weisskirchner Barfod1*, Maria Swennergren Hansen2, Per Holmich3, Anders Troelsen1
and Morten Tange Kristensen2
Abstract
Background: Early controlled ankle motion is widely used in the non-operative treatment of acute Achilles tendon
rupture, though its safety and efficacy have never been investigated in a randomized setup. The objectives of this
study are to investigate if early controlled motion of the ankle affects functional and patient-reported outcomes.
Methods/design: The study is performed as a blinded, randomized, controlled trial with patients allocated in a 1:1
ratio to one of two parallel groups. Patients aged from 18 to 70 years are eligible for inclusion. The intervention
group performs early controlled motion of the ankle in weeks 3–8 after rupture. The control group is immobilized.
In total, 130 patients will be included from one big orthopedic center over a period of 2½ years. The primary
outcome is the patient-reported Achilles tendon Total Rupture Score evaluated at 12 months post-injury. Secondary
outcome measures are the heel-rise work test, Achilles tendon elongation, and the rate of re-rupture. The primary
analysis will be conducted as intention-to-treat analyses.
Discussion: This trial is the first to investigate the safety and efficacy of early controlled motion in the treatment of
acute Achilles tendon rupture in a randomized setup. The study uses the patient-reported outcome measure, the
Achilles tendon Total Rupture Score, as the primary endpoint, as it is believed to be the best surrogate measure for
the tendon’s actual capability to function in everyday life.
Trial registration: ClinicalTrials.gov: NCT02015364. Registered on 13 December 2013.
Keywords: Achilles tendon, Achilles tendon rupture, Non-operative treatment, Dynamic mobilization, Early
controlled motion
Background
One out of three patients has a poor outcome after treat-
ment for acute Achilles tendon rupture [1, 2]. It is a fre-
quent (20 to 32 per 100,000 per year) and potentially
debilitating injury that typically affects young active adults
[3, 4]. Consequently, there are great socioeconomic bene-
fits in optimizing treatment and shortening recovery.
There is currently no consensus regarding the best
treatment for acute Achilles tendon rupture. Tradition-
ally, operative treatment has been considered superior;
however, recent studies show that non-operative
treatment is a safe treatment which leads to good results
[5–7]. For this reason there has been a transition to-
wards greater use of non-operative treatment in many
orthopedic departments [8].
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However, the optimal non-operative treatment proto-
col has yet to be clarified. Typically the treatment
consists of 8 weeks of immobilization in a cast or orth-
osis with rehabilitation of the calf muscles and Achilles
tendon beginning after week 8 [9, 10]. Since the 1980s
the impact of early controlled motion of the ankle joint
has been discussed [11–13]. In theory, early controlled
motion of the tendon leads to a better and faster healing
due to, inter alia, the release of growth factors [14].
Clinical studies looking at flexor tendons have found
controlled early movement to promote faster and better
healing [15, 16]. Animal studies have shown a three
times increased strength in mobilized Achilles tendons
compared to the immobilized ones [17]. Three random-
ized studies of patients with acute Achilles tendon rup-
ture have compared operative and non-operative
treatment using a dynamic rehabilitation protocol in
both groups [18–20]. They show good results for both
operative and non-operative treatment. In 2007 Twaddle
and Poon concluded that: ”possibly, controlled early
motion is the important factor in optimizing outcomes
in patients with acute Achilles tendon rupture and sur-
gery makes no difference to the outcome apart from
increasing the risk of local infection” [18].
In 1992 Saleh et al. investigated the effect of early con-
trolled ankle motion in non-operative treatment of acute
Achilles tendon rupture in a semi-randomized study of
40 patients [11]. The group which was allowed early
controlled motion had improved mobility of the ankle
joint after 3 and 6 months but not after 12 months.
There were no other significant differences between the
groups. Since then, various randomized trials of varying
quality have studied the effect of early controlled motion
after operative treatment [12, 13, 21, 22]. They find in-
creased mobility of the ankle joint within the first
6 months but otherwise no significant differences. One
study finds a less pronounced elongation of the Achilles
tendon in the group with early controlled motion [23].
Meanwhile, animal studies have shown that early con-
trolled motion of the ankle joint can lead to elongation
of the Achilles tendon [24], and elongation of the Achil-
les tendon has been shown to cause decreased push-off
strength and thus a poor functional outcome [23, 25].
Several Nordic hospitals have, on the basis of the pre-
ceding results, changed their treatment algorithms to
feature early controlled motion [8]. However, it has
never been investigated, involving patients in a random-
ized setup, whether early controlled motion of the ankle
joint is beneficial for the healing of the Achilles tendon
in a non-operative treatment protocol.
With this project we wish to investigate the effect of
early controlled motion of the ankle joint from day 14
following non-operative treatment. We will compare this
to a traditional treatment protocol where the ankle joint
is immobilized for 8 weeks. Full weight bearing is
allowed from day 14 in both groups.
Hypothesis: The optimal loading of the Achilles ten-
don, and thereby the optimal healing condition, is
achieved by early controlled motion of the ankle joint.
This will result in a strong tendon with a shorter length
than for immobilized ankle joints. The patient-allowed
motion of the ankle will experience a better functional
outcome and a better patient-reported health in com-
parison with immobilization.
Null hypothesis: There is no difference in the func-
tional outcome or in patient-reported outcome when
early controlled motion of the ankle joint is compared to
immobilization.
Methods/design
This is a report of the second version of the trial proto-
col dated 26 March 2014. Any important protocol modi-
fications will be communicated through
ClinicalTrials.gov, the Ethical Review Board, and the Tri-
als journal. The protocol was developed in accordance
with the guidelines and checklists for Standard Protocol
Items: Recommendations for Interventional Trials
(SPIRIT; see Additional file 1) and Consolidated Stan-
dards of Reporting Trials (CONSORT).
Design
The study is performed as a blinded, randomized, con-
trolled trial (RCT) with patients allocated in a 1:1 ratio
to one of two parallel groups. In total 130 patients will
be included.
Objective
The primary objective of the study is to investigate if
early controlled motion of the ankle in weeks 3–8 post-
injury affects the patient-reported outcome after non-
operative treatment of acute Achilles tendon rupture
compared to patients not allowed any motion of the
ankle.
Primary outcome measure
The primary outcome measure is the Achilles tendon
Total Rupture Score (ATRS) evaluated at 12 months
post-injury. The ATRS is a patient-reported score devel-
oped to assess symptoms and physical activity after
treatment for acute Achilles tendon rupture [26].
Secondary outcome measures
The secondary outcome measures are listed below.
(The timing of the assessments is shown in Fig. 3.)
 Heel-rise work test: Endurance test where the
patient stands on one leg and lifts the heel up and
down until exhaustion. The number and the height
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of the heel-rises are counted and measured. The
results are then compared to the weight of the
patient, and the total work is estimated. The
MuscleLab ® (Ergo Test Technology, Oslo, Norway)
measurement system is used [26].
 Single heel-rise test: The patient stands with the foot
in 10 degrees of dorsiflexion. It is recorded whether
the patient is able to make a single heel-rise on the
injured leg. The heel-rise is acknowledged if the heel
can be lifted at least 2 cm with stretched knee. The
MuscleLab ® (Ergo Test Technology, Oslo, Norway)
measurement system is used [27].
 Ultrasonographic tendon length: The length
between the calcaneus and the distal tip of the
medial head of the gastrocnemius muscle [28].
 Cost-effectiveness analysis: A cost-effectiveness
analysis will be performed comparing the two
treatment protocols.
 Re-rupture.
 Perimeter of calf [29].
 Type of work and return to work.
 Type of sport and return to sport.
 Achilles tendon resting angle (ATRA) [29].
 Achilles tendon length measure (ATLM).
 Plantar flexion power is measured with a hand-held
dynamometer fixed to the examination bed with a
strong Velcro band.
 Deep vein thrombosis (DVT) screening by Doppler
ultrasonography.
Study participants
Patients who are treated for acute Achilles tendon rup-
ture at Copenhagen University Hospital Hvidovre are
eligible for inclusion if they fulfill the inclusion criteria.
Patients who do not wish to participate are treated non-
operatively without early controlled motion of the ankle
joint.
Inclusion criteria
The inclusion criteria are as follows:
 Age 18–70 years.
 The patient must be expected to be able to attend
rehabilitation and post-examinations.
 The patient must be able to speak and understand
Danish.
 The patient must be able to give informed consent.
Exclusion criteria
The exclusion criteria are as follows:
 Former rupture of one or both Achilles tendon(s).
 Previous surgery on the Achilles tendon.
 Fluoroquinolone treatment within the last 6 months.
 Tendinosis treated with corticosteroids
(tablets or injections) within the last 6 months.
 Diagnosis of arterial insufficiency in the legs.
 Terminal illness or severe medical illness: American
Society of Anesthesiologists (ASA) score higher than
or equal to 3.
 The space between the rupture and the calcaneus is
less than 1 cm.
Recruitment organization
The day after primary treatment at the emergency room,
patients are attended to in the outpatient clinic. The
patients are examined by an investigator, who assesses
whether the patient meets the inclusion criteria. If so,
the patient is verbally informed of the study and is given
written patient information. The patient is given the
opportunity — on an informed basis without any pres-
sure — to decide whether he/she wants to participate in
the trial. The patient is informed of his/her right to
24 hours of reflection.
Randomization
Participants will be randomly assigned to either the
control or experimental group with a 1:1 allocation as
per a computer-generated randomization. An experi-
enced senior researcher with no other connection to the
trial is responsible for generation of the allocation key
and creation of numbered, opaque, and sealed envelopes.
The allocation key is stored by and only accessible to the
senior researcher. If a participant needs to know the
allocated treatment ahead of trial termination, this will
be arranged by the project nurse. Randomization is
performed by the project nurse.
Blinding
The physiotherapists who conduct the follow-up exami-
nations and the primary investigator conducting the data
analysis are blinded to the intervention. Patients and in-
vestigators are not blinded to delivery of the intervention
and control. All patient contact in the treatment period
from weeks 2 to 8 is coordinated by a project nurse, a
physiotherapist, and an orthopedic surgeon with no con-
nection to the follow-up visits and data analysis.
Time schedule
Recruitment of patients for the study began in February
2014 and was finished in November 2016. Final follow-
up will be conducted in November 2018.
Setup
Place of investigation
The trial is taking place at Copenhagen University
Hospital Hvidovre, Denmark. At this hospital patients
with acute Achilles tendon rupture are recommended
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non-operative treatment with the following exceptions: (1)
ruptures older than 5 days, (2) degenerative ruptures
(patients treated with steroids or fluoroquinolones within
the last 6 months), and ruptures within 1 cm of calcaneus.
Intervention
A cast is applied in the emergency room and changed to a
circular scotch cast in the outpatient clinic within 4 days.
No weight bearing on the injured leg is allowed within the
first 2 weeks post-injury. After 2 weeks the cast is changed
to a removable orthosis, and full weight bearing is allowed.
At this point patients who choose to participate in the trial
are, through randomization, placed in one of the following
two groups (see Fig. 1): (1) the intervention group, which
must perform controlled ankle motion exercises from the
beginning of week 3 through week 8 or (2) the control
group; in line with the current treatment regimen, the
patients must keep the orthosis on at all times, and they are
not allowed to move the ankle before week 9. The treat-
ment protocols for the two groups are similar except for
the intervention: early controlled motion of the ankle
(Fig. 2).
Compliance
To ensure compliance within the groups, the patients of
the intervention group are equipped with training diaries
in which they record their training for each of the five
daily training sessions. The patients in the control group
have their orthosis sealed with a plastic strap designed
for the purpose. If the orthosis is removed between
clinical follow-ups, it is registered by the project nurse.
Detailed description of the examination and treatment
weeks 0–8
The following treatment protocol is similar for both
groups.
Day 0: In the emergency department the diagnosis is
made based on the following criteria: (1) a patient history
with a clear sense of ”snap” of the Achilles tendon, (2) a
palpable defect, usually located 3–6 cm above the calca-
neal tubercle, and (3) a positive calf squeeze test [30]. A
plaster of Paris is applied to the patient’s foot in a planti-
grade position (30–45 degrees). No weight bearing is
allowed.
Days 1–3: The diagnosis is confirmed by a physiother-
apist specialized in treatment of acute Achilles tendon
rupture, and the foot is put in a circular scotch cast with
the foot in a plantigrade position. Verbal and written
information on the project is delivered to the patient.
Day 14: The cast is changed to a removable orthosis
(AirCast AirSelect Standard from DJO Global, Vista,
CA, USA) with two 1.5-cm heel lift wedges. Full weight
bearing is allowed, but the patient is advised to use
crutches for another week or two. Randomization is
performed.
Week 4: The patient is seen by the project nurse, and
the first wedge is removed. For the intervention group,
the training diary is inspected and patients are encour-
aged to do their home exercises. For the control group,
the seal is broken and the foot is gently washed before
reapplying the seal.
Week 6: The patient is seen by the project nurse, and
the second and last wedge is removed. For the interven-
tion group, the training diary is inspected and patients
are encouraged to do their home exercises. For the con-
trol group, the seal is broken and the foot is gently
washed before reapplying the seal.
Week 8: The orthosis is removed, and the tendon is
inspected. Tendon healing is examined clinically and by
ultrasound. During the following 4 weeks, crutches are
used as needed, and the orthosis is used in situations of
high strain/risk.
Detailed description of the rehabilitation weeks 9–16
Rehabilitation from week 9 to 16 is the same for the two
groups, and is organized as group exercises twice a week
at the hospital. A standardized rehabilitation program
inspired by Willits et al. and Nilsson-Helander et al. is
used (Table 1) but adjusted individually if needed [19,
20]. The sessions are led by physiotherapists and last for
60 minutes.
Fig. 1 Study design
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Follow-up investigations
Follow-up is performed at 4 months, 6 months, 1 year,
and 2 years (Fig. 3). The study’s primary endpoint is
at the 12 months follow-up. Follow-up is performed
by blinded physiotherapists. Before entering the exam-
ination room, the patients are reminded by a
secretary not to reveal which treatment group they
belong to.
Patients who discontinue the treatment are still
encouraged to participate in the follow-up. They are
contacted up to three times via mail or telephone.
Registration and availability of data
All relevant data are recorded in specially designed
case report files. The patients are identified by an
assigned number. At the completion of the study, all
identifiable data will be destroyed. The patients are
informed, both verbally and in writing, that data are
stored and analysed in a computer, that the patient’s
anonymity is preserved, and that the data protection
legislation is adhered to. The data registration is
reported to the Danish Data Protection Agency, iden-
tifier HVH-2014-002, I-Suite no. 02608. The list of
registered data is included in Fig. 3. There will be
free access to the final anonymized trial dataset. Due
to the limited size of the study and the safety of the
treatments, a data monitoring committee is not
considered necessary.
Statistics and analysis
Sample size
Sixty-five patients will be included in each group, thus
130 patients in total. The sample size calculation is
based on a clinical relevant difference of 10 points in
ATRS, a standard deviation (SD) of 16, and power of
0.90 (two sided). In a previous study with a fully com-
parable population, we found an SD of 16 points at the
1 year post-examination [1]. Fifty-four patients are
required in each group; due to the risk of dropout, 65
patients will be included in each group.
Analysis of endpoints
The two groups are described with regard to demo-
graphic parameters as well as primary and secondary
endpoints. The primary and secondary outcomes of both
groups are compared by the use of relevant statistics
according to the characteristics and distribution of the
variables. The change of the outcomes over a period of
time is described within each group.
All statistical testing will be performed at the two-
sided 5% significance level, and 95% confidence intervals
will be presented where appropriate. No formal interim
analyses are planned, and hence no statistical testing will
take place until the 1 year analysis. The 1 year analysis
will take place after all participants have completed their
1 year follow-up and sufficient time has been allowed for
data entry and validation.
Fig. 2 The intervention: early controlled motion of the ankle joint. The orthosis is removed with the patient sitting on the edge of a table with
both legs hanging. Gravity bends the foot downward, whereupon the patient must actively flex the foot upwards to a horizontal position. This is
done at least five times a day in series of 25 repetitions
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Prior to any analysis, missing data patterns will be in-
vestigated and reasons for missing data obtained and
summarized where possible. The primary analysis will be
conducted as an intention-to-treat analysis, which in-
cludes all participants with missing outcome data, unless
there is clear evidence that its underlying assumption is
inappropriate. A sensitivity analysis will be performed to
assess the robustness of the results by imputing missing
data using multiple imputation under both missing at
random and missing not at random assumptions.
Safety
Risks and side effects
Non-operative treatment of Achilles tendon rupture with
or without early controlled motion of the ankle joint is a
safe treatment used in orthopedic departments all over
the country. At Copenhagen University Hospital Hvi-
dovre we have periodically used first one and then the
other regimen without registered risks and side effects
for patients. One can theoretically argue that patients
allowed early movement of the ankle joint are at risk of
healing with an elongation of the Achilles tendon. More-
over, there is always the risk of unknown side effects. Pa-
tients participating in the trial are covered by the patient
insurance of Copenhagen University Hospital Hvidovre.
Adverse events
In this context an adverse event is defined as any unin-
tended, unfavorable finding, symptom, or disease that
occurs, whether it is considered to be related to the
study or not. Adverse events will be recorded.
Critical adverse events
In this context a critical adverse event is defined as an
event or reaction which will cause: death, life-threatening
situations, hospitalization or prolongation of existing
hospitalization, or permanent or severe disability.
Critical adverse events must be assessed by an investi-
gator regarding possible correlations with the trial’s
modified treatment in order to consider whether there is
a reasonable possibility that this caused the adverse
event. The following factors are included in the assess-
ment: consistency in time, consistency with the known
effects of treatment, and alternative causes.
If a critical adverse event is considered to have a causal
relationship with the treatment, then the project man-
ager and other clinically responsible investigators will
evaluate whether the study should be terminated.
Satellite studies
Separate protocols have been written for the following
substudies.
Ultrasonographic-guided treatment of acute Achilles tendon
rupture: evaluation of two novel ultrasonographic
measurements
This study will validate Amlang’s ultrasound classifica-
tion and investigate whether the treatment of acute
Achilles tendon ruptures can be guided by (1) Amlang’s
Table 1 Rehabilitation weeks 9–16
Basic exercises
Exercise bike: 10–15 min
Ankle range of motion (pronation and supination, dorsal and plantar
flexion. Dorsal flexion to 90 degrees. The other movements
unlimited): 2 × 8 reps
Standing heel-rise (2 × 3 s tempo) 3 × 10 repsa
One leg standing balance exercise: 3 × 30 sa
Weeks 9–11
Basic exercises
Exercises with resistance band around the foot in sitting position
(knee extended, dorsal flexion to 90 degrees, plantar flexion and
inversion): 2 × 20 reps
Side laying hip abduction: 2 × 15 reps
Heel-rise in supine position with flexed legs: 2 × 15 reps
Sitting heel-rise with weight on injured leg (20–25 repetitions
maximum): 3 × 15 reps
Gait training
Once a week, the training is situated in a pool where similar exercises
are performed.
Weeks 12–16
Basic exercises (as above)
Walk on toes with support to start with, if needed: 2 × 5 m
Standing heel-rise is performed with increased weight on injured
leg: 5 × 10 reps
Heel-rise in supine position with flexed legs (with increased weight
on injured leg): 2 × 15 reps
Leg press with one leg at a time (10 repetitions maximum): 2 × 10
reps
Balance exercise on a trampoline: 2 × 45 s
Walk/jog on a trampoline: 2 × 45 s
Cross trainer: 1 min and 45 s
Lunges (only with injured leg in front): 2 × 10 reps
The plank (core exercise): 2 × 45 s
This program is performed as circle training.
Return to running—from week 14
Jogging upwards on stairs is allowed when the patient can walk 5 m
on toes without heel falling down.
Running on even ground is allowed when the patient can perform 5
single-legged heel-rises with approximately 90% of the height of the
un-injured leg.
After completed rehabilitation program
Examination of tendon healing and function. If needed, referral to
further physiotherapy. Gradual return to sports (contact sports earliest
6–9 months after injury)
aHome exercises, three times daily
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ultrasound classification of acute Achilles tendon rup-
ture [31] or (2) Barfod’s ultrasound measurement to
determine the elongation of the Achilles tendon follow-
ing a rupture [28]. The study is registered at Clinical-
Trials.gov: NCT02062567.
Metabolic complications following Achilles tendon rupture
This study will evaluate the effect on glucose, lipid, and
bone metabolism following conservative orthopedic
procedures in patients who suffered from acute Achilles
tendon rupture. We want to investigate the putative
negative impact on glucose, lipid, and bone metabolism
during a period of restraint from exercise secondary to
immobilization following Achilles tendon rupture. We
also want to study these patients during their physical
active rehabilitation (at weeks 8–52) to establish whether
they succeed in improving the metabolic impairments
they suffered during the early post-injury period, during
Fig. 3 SPIRIT table of enrollment, interventions, and assessments
Barfod et al. Trials  (2016) 17:564 Page 7 of 10
which strong limitations on physical activity are pre-
scribed (weeks 0–8). The study is registered at Clinical-
Trials.gov: NCT02015364.
Risk of deep vein thrombosis in non-operative treatment for
acute Achilles tendon rupture
This study will investigate the risk of deep vein throm-
bosis (DVT) in non-operative treatment for acute Achil-
les tendon rupture in the presence of a risk-stratified
protocol for antithrombotic treatment. All study patients
are investigated for DVT by use of blood samples and
Doppler ultrasonography performed by an experienced
radiologist at 2 and 8 weeks.
Discussion
The intervention
The content of the intervention was carefully selected
based on the experience of a finished Ph.D. study [32].
Early controlled motion of the ankle can be performed
in different ways: some use hinged orthoses allowing for
movement of the foot while walking and resting [11, 19],
while others use fixed orthoses that are to be removed
for allowance of movement of the ankle [1]. In the time
period leading up to this study, different orthoses were
tried and evaluated in the department. A fixed orthosis
was chosen, as it seemed the most reliable choice in the
study setup. The chosen motion protocol is based on the
one developed by Willits et al. [20]. It is, however, debat-
able how often the ankle is to be taken out of the orth-
osis and how many exercises should be performed. The
hinged orthoses were opted out due to technical prob-
lems with adjustment of the center of rotation and anx-
iety of putting too large a strain on the healing tendon.
Endpoints
For this study the patient-reported outcome measure
ATRS [26] was chosen as the primary endpoint. It is val-
idated in a Danish context [33] and has been increas-
ingly used since its publication in 2007 [1, 19, 34]. The
score reports the patient perception of the function of
the healed tendon and not the actual function of the
tendon. The incidence of Achilles tendon ruptures peaks
in the early 40s [3], the age period in which many people
reduce their physical activities and change their pattern
of exercise and sporting activities. Therefore, patients
might not register impairments leading to decreased
physical capabilities, and a high ATRS might be due to
low demands of the tendon and not a well-functioning
tendon. Following this argument, a physical endurance
test like the heel-rise work test [35] or a measurement of
tendon length [28, 29] might constitute better primary
endpoints. However, these measurements are very spe-
cific and do not describe the tendon’s actual capability to
function in everyday life. Thus, the ATRS was chosen
for this study.
Compliance
Compliance to the allocated treatment protocol is im-
portant in order to be able to measure the effect of the
intervention. In the present study, compliance is mea-
sured with a training diary in the intervention group and
a seal of the orthosis in the control group. The possibil-
ity of measuring compliance with use of motion sensors
was investigated prior to the trial but found impossible.
Changes to the protocol
Minor changes were performed between the first and
the second versions of the protocol. The first version,
dated 29 November 2013, was used for institutional re-
view board (IRB) approval and clinical trial registration.
The changes did not affect the essential parts of the
protocol and did not lead to any changes in the trial
registration. The second version of the protocol was ac-
cepted by the Ethical Review Board of the Capital Region
of Denmark on 5 August 2014.
Trial status
The trial commenced in February 2014. Recruitment
was originally expected to span 2 years, but due to initial
slow recruitment it is now expected to span 2½ years. By
the end of February 2016, 110 of 130 patients had been
included.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents*. (DOC 122 kb)
Abbreviations
ASA: American Society of Anesthesiologists; ATLM: Achilles tendon length
measure; ATRA: Achilles tendon resting angle; ATRS: Achilles tendon Total
Rupture Score; CONSORT: Consolidated Standards of Reporting Trials;
DVT: Deep vein thrombosis; RCT: Randomized controlled trial; SD: Standard
deviation; SPIRIT: Standard Protocol Items: Recommendations for Interventional
Trials
Acknowledgements
The study is facilitated by the Department of Orthopedic Surgery and the
Department of Physiotherapy and Occupational Therapy, Copenhagen
University Hospital Hvidovre. The authors would like to convey a special thanks
to the respective heads of departments Peter Gebuhr and Jette Christensen,
who made the study possible due to their vision and interest in research. The
authors thank all participants for their involvement in the study.
Funding
The trial’s main sponsors are the Department of Orthopedic Surgery and the
Department of Physiotherapy, Copenhagen University Hospital Hvidovre.
DJO Global is contributing 44,000€ according to a detailed research grant
agreement. The Danish Rheumatism Association, the Danish Medical
Research Grant, and a few private non-profit foundations have contributed
amounts of less than 11,000€.
The project group has independently initiated the study. Funders have not
had and will not have any role or authority concerning study design;
Barfod et al. Trials  (2016) 17:564 Page 8 of 10
collection, management, analysis, and interpretation of data; writing of the
report; and the decision to submit the report for publication. Patients do not
receive any fees for participation.
Availability of data and materials
The final anonymized dataset will be available from the first author upon
request.
Authors’ contributions
The project manager, KWB, holds in close cooperation with the last author,
MTK, the overall responsibility for all phases of the study. Both KWB and MTK
are actively taking part in these (study design; collection, management,
analysis, and interpretation of data; writing of the report and publication).
The second author, MSH, is responsible for correct completion of data sheets
and data collection as well as storing the data according to the guidelines of
the Danish Data Protection Agency. Furthermore, she has been taking part in
the design of patient flow and collection of data. AT and PH have taken part
in designing the study and the logistical procedures concerning data
collection and management. Data analysis and interpretation of data as well
as writing of the paper are done by KWB and MTK in close cooperation with
the study group. All authors read and approved the final manuscript.
Authors’ information
Kristoffer Weisskirchner Barfod, M.D. Ph.D., is a consultant in orthopedic
surgery at Copenhagen University Hospital Hvidovre. He is part of the
research environment’s Clinical Orthopedic Research Hvidovre (CORH) and
Sports Orthopedic Research Center - Copenhagen (SORC-C). Maria
Swennergren Hansen, P.T., is responsible for rehabilitation of patients with
Achilles tendon rupture at Copenhagen University Hospital Hvidovre. She is
part of the research environment’s Physical Medicine and Rehabilitation
Research - Copenhagen (PMR-C). Professor Per Holmich, M.D. D.M.Sc., is chief
surgeon at the arthroscopic center, Department of Orthopedic Surgery at
Copenhagen University Hospital Hvidovre. He is head of research for Sports
Orthopedic Research Center - Copenhagen (SORC-C). Professor Anders
Troelsen, M.D. Ph.D. D.M.Sc., is a consultant in orthopedic surgery at
Copenhagen University Hospital Hvidovre. He is head of research for Clinical
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steering committee for Physical Medicine and Rehabilitation Research -
Copenhagen (PMR-C).
Competing interests
DJO Global has provided a significant contribution to the trial. The company
has not at any time shown a special interest in the study design or any
other vital part of the project. The authors do not recognize that one
outcome would be more beneficial than the other for the company. As
such, the company’s incentives to influence the trial are believed to be
non-existing. None of the investigators have financial or other competing
interests in relation to the trial.
Consent for publication
All patients are giving written consent for publication.
Ethics approval and consent to participate
Ethical approval was obtained on 18 December 2013 from the Ethical
Review Board of the Capital Region of Denmark, identifier: H-4-2013-176.
The departments of Orthopedic Surgery and Physical and Occupational
Therapy, Copenhagen University Hospital Hvidovre, are highly specialized
departments that master both conservative as well as surgical treatment of
Achilles tendon ruptures at the highest level. We believe that the potential
benefits for the patients enrolled in the study (better functional outcomes,
improved health-related well-being, and economic savings) exceed the
potential inconveniences (additional follow-up audits and possible risks/side
effects).
The study is carried out in accordance with the principles of the Helsinki
Declaration. Patients are covered by the patient insurance of Copenhagen
University Hospital Hvidovre. The project manager is responsible for
informing the National Committee on Health Research Ethics of any critical
adverse event and/or major changes of the protocol. All correspondence will
be filed by the project manager.
All patients will receive verbal and written information concerning the study.
The inclusion will take place after a declaration of consent has been
obtained. It is the responsibility of the investigators to provide patients with
comprehensive verbal and written information concerning the course of the
study, purpose, and potential risks and benefits.
Upon including a patient, he/she will be informed of the scientific aspects of
the study, that he/she has the right to bring a lay representative to the first
information meeting, and that he/she has the right to 24 hours of reflection
after receiving verbal and written information on the study.
The verbal information follows the content of the written information, which
will be reviewed together with the patient where specific content will be
elaborated if needed. The verbal information will be tailored according to
age, social conditions, and educational level of the patient. The investigator
in question will ensure that the patient is thoroughly informed of the
contents of the study. The verbal information is given under undisturbed
conditions at a scheduled time in the physiotherapy department or
orthopedic clinic. The project manager must ensure that the investigator or
other authorized person who is presenting a patient with information is
thoroughly informed of the project and professionally qualified to provide
information.
Publication
The project manager will prepare the script and be the first author. The
other investigators will appear as co-authors of the article, if they at the time
of submission have fulfilled the Vancouver rules for authorship regarding
scientific articles.
It is expected that the study will be published in an international, high-impact
journal. We will furthermore seek to have the results presented at both national
and international medical congresses. The results will also be published online
and in other relevant media. There are no publication restrictions. There is
public access to the full-protocol, participant-level dataset and statistical code.
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